29/12/2009
Cell Therapeutics, Inc.
SEATTLE, Dec. 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that on December 24, 2009, CTI's Board of Directors (the "Board of Directors") rejected and dropped a Shareholder Rights Plan (the "Rights Plan") in which one preferred stock purchase right could be distributed for each common share held as of the close of business on January 7, 2010. Initially, the rights are exercisable, and are attached to and trade with, all of the shares of CTI's common stock outstanding as of, and issued subsequent to, the record date.
Subscribe to:
Post Comments (Atom)
SOUTH AFRICA SPRINGBOKS
South Africa laid the groundwork with traditional Springbok rugby and finished an out-gunned England side off with two late tries to win ...
-
The year 2007 is almost over, all the happenings we had along the year all affected the final consumer price, but the most used by oil compa...
-
Our WorldWatch received news fresh from Joburg that AngloGold, Africa's biggest gold producer, employs about 35,000 people in South Afr... -
The Mannheim-based ZEW Center for European Economic Research reported that investor confidence in Germany dropped to the lowest in almost 1...
No comments:
Post a Comment